Key result
Mitral valve repair is the preferred surgical management for most cases of mitral valve insufficiency, offering better outcomes and lower mortality compared to valve replacement.
This review highlights that mitral valve repair remains the procedure of choice over replacement for mitral insufficiency across multiple etiologies, offering better long-term outcomes.
Answers are grounded in this paper and cite their sources.
Supports repair preference in mitral insufficiency; leaves open etiology-specific durability questions for prospective trials.
Mitral valve (MV) dysfunction is the second-most common clinically significant form of valvular defect in adults. MV regurgitation occurs with the increasing frequency of degenerative changes of the aging process. Moreover, other causes of clinically significant MV regurgitation include cardiac ischemia, infective endocarditis and rhematic disease more frequently in less developed countries. Recent evidence suggests that the best outcomes after repair of severe degenerative mitral regurgitation (MR) are achieved in asymptomatic or minimally symptomatic patients, who are selected for surgery soon after diagnosis on the basis of echocardiography. This review will focus on the surgical management of mitral insufficiency according to its aetiology today and will give insight to some of the perspectives that lay in the future.
No takes yet. Share an insight, caveat, or question.
Madesis et al. (2014) conducted a review in Mitral valve insufficiency. Mitral valve repair vs. Mitral valve replacement was evaluated. Mitral valve repair is the preferred surgical management for most cases of mitral valve insufficiency, offering better outcomes and lower mortality compared to valve replacement.
Synapse has enriched 10 related papers. Consider them for comparative context: